PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Poo-romising frontier in fecal microbiota transplantation

Poo-romising frontier in fecal microbiota transplantation
2025-04-10
(Press-News.org) Helicobacter pylori (H. pylori) is a widespread bacterial infection associated with gastritis, peptic ulcers, and gastric cancer. While conventional antibiotic-based treatments have been the gold standard for eradication, their efficacy has been steadily declining due to the alarming rise in antibiotic resistance. This has spurred interest in alternative therapies, one of which is fecal microbiota transplantation (FMT).

FMT is a novel therapeutic approach that involves transferring microbiota from a healthy donor to a patient’s gastrointestinal tract. This process aims to restore microbial balance and has shown promise in treating various gastrointestinal disorders, particularly Clostridioides difficile infections. Recent research suggests that FMT could play a pivotal role in the eradication of H. pylori, either as a monotherapy or an adjunct to conventional treatments.

The study, published in eGastroenterology, provides an in-depth analysis of FMT’s potential mechanisms in H. pylori eradication. One of the primary hypotheses is that the diverse microbial community introduced through FMT may outcompete H. pylori, preventing its colonization. Additionally, beneficial bacteria in the transplanted microbiota produce antimicrobial peptides and metabolic byproducts that create a hostile environment for H. pylori.

Another key finding of the study is that FMT may help mitigate the adverse effects commonly associated with antibiotic treatments for H. pylori. Standard eradication regimens often involve multiple antibiotics combined with proton pump inhibitors, which can lead to gastrointestinal discomfort, taste disturbances, and nausea. FMT’s ability to restore gut microbiota homeostasis could reduce these side effects and enhance patient tolerance to therapy.

Clinical trials have provided preliminary support for FMT’s efficacy in H. pylori treatment. One pilot study reported a 40.6% eradication rate with FMT alone, a figure higher than that observed with probiotic monotherapy. When used as an adjunct to high-dose dual therapy, FMT did not significantly increase eradication rates but was found to improve gastrointestinal symptom scores and reduce the incidence of treatment-related adverse effects. These findings underscore the need for further investigation to refine FMT protocols and maximize its therapeutic potential.

While FMT’s promise in H. pylori treatment is encouraging, several challenges remain. Donor selection is a critical factor influencing treatment success, as variations in microbiota composition can impact FMT efficacy. Optimizing the preparation and delivery of fecal suspensions is also essential, with emerging research suggesting that washed microbiota transplantation (WMT) may enhance safety and effectiveness.

Moreover, the study highlights the need to explore the specific mechanisms through which FMT exerts its effects on H. pylori. Apart from bacteria, other components within the fecal suspension, such as bacteriophages and microbial metabolites, may play a role in disrupting H. pylori colonization. Further research is required to elucidate these interactions and identify the key bioactive factors responsible for FMT’s therapeutic effects.

Another crucial aspect for future research is the identification of patient populations most likely to benefit from FMT. Factors such as age, gut microbiota composition, and pre-existing gastrointestinal conditions may influence treatment outcomes. Additionally, given that H. pylori reinfection rates remain a concern, long-term follow-up studies are necessary to assess FMT’s durability in preventing recurrence.

FMT represents a paradigm shift in the approach to H. pylori eradication, offering a potential solution to the challenges posed by antibiotic resistance. While the field is still in its early stages, the accumulating evidence supports the need for large-scale clinical trials to validate FMT as a viable alternative or adjunct to existing treatments. If proven effective, FMT could revolutionize the management of H. pylori infection and pave the way for microbiota-based therapies in other gastrointestinal disorders.

 

See the article: 

Ye Z-N, Eslick GD, Huang S-G, et al. Faecal microbiota transplantation for eradicating Helicobacter pylori infection: clinical practice and theoretical postulation. eGastroenterology 2024;2:e100099. doi:10.1136/egastro-2024-100099

 

About eGastroenterology

eGastroenterology is a new, open-access, and open peer-reviewed BMJ Journal, which focuses on basic, clinical, translational, and evidence-based medicine research in all areas of gastroenterology (including hepatology, pancreatology, esophagology, and gastrointestinal surgery). eGastroenterology is now indexed by PubMed, Scopus, CAS, DOAJ, Dimensions, OpenAlex, ROAD, and COPE, with more to come!

For more information, please visit: egastroenterology.bmj.com and follow us on Twitter (@eGastro_BMJ).

Sign-up to Email Alerts for eGastroenterology: https://emails.bmj.com/k/Bmj/jausu/egastroenterology

END


[Attachments] See images for this press release:
Poo-romising frontier in fecal microbiota transplantation

ELSE PRESS RELEASES FROM THIS DATE:

A new approach to differentiating large granular lymphocytic leukemias and their mimics in light of current updates in the 5th Edition of the WHO Classification

2025-04-10
Large granular lymphocytic leukemias (LGLLs) are a heterogeneous group of rare chronic lymphoproliferative disorders characterized by the clonal proliferation of cytotoxic lymphocytes. Among them, T-cell LGLL (T-LGLL) and NK-cell LGLL (NK-LGLL) are the most prominent. Due to overlapping morphological, clinical, and immunophenotypic characteristics, distinguishing these disorders from related entities such as T-prolymphocytic leukemia (T-PLL), adult T-cell leukemia/lymphoma (ATLL), Sézary syndrome (SS), and aggressive NK-cell leukemia (ANKL) presents a significant diagnostic challenge. This review integrates recent molecular insights and updates from the WHO 5th edition ...

Simple and cost-effective reporter assay for evaluating chemical-induced epigenetic changes

Simple and cost-effective reporter assay for evaluating chemical-induced epigenetic changes
2025-04-10
Chemicals used as food preservatives, flavoring agents, dyes, pesticides, cosmetics, cleaners, and other industrial materials are being increasingly recognized as a health hazard. Their rampant use has led to an increase in the prevalence of various chemical toxicity-induced diseases, including hormonal disruption, cancer, neurological disorders, skin conditions, and occupational poisoning. Numerous chemicals are known to trigger “carcinogenesis” or cancer development by exerting genotoxic effects (direct or indirect interference with DNA replication and damage repair processes ...

Scientists say the “plant world” needs to come out and claim its place at the One Health table

Scientists say the “plant world” needs to come out and claim its place at the One Health table
2025-04-10
Scientists writing a policy forum article in the CABI One Health journal say the “plant world” needs to come out and claim its place at the One Health table as part of a desire to break down barriers that currently limit true cross-domain integration. The researchers say that while plant health is increasingly recognized as a vital part of One Health, it lacks recognition and – historically focussed on health service provision, zoonotic diseases and antimicrobial resistance – One Health overlooks plant health in strategic plans. They add that cross-sectoral approaches, core to One Health, are already used ...

A new tool to improve lives after brain injury is underway at The University of Texas at San Antonio

2025-04-10
Traumatic brain injury (TBI) is a serious issue affecting thousands of people in the U.S. every year. For military service members, the impact is even more profound. Since 2000, over 492,000 cases of TBI have been reported, making it one of the defining injuries of modern warfare, according to the U.S. Department of Defense. Many veterans have experienced multiple TBIs, raising concerns about long-term effects on brain health. Given the subjective and nonspecific nature of symptom presentation, treatment and prognosis can be difficult. Researchers ...

Guinea pigs: A promising animal model to study the human embryo

2025-04-10
The first few days of a human embryo’s development, known as pre-implantation, are important. It’s when the first cells are formed, and these decide if the embryo can survive, how it will implant in the womb and how the tissues of the fetus will develop. Today there are still logistical, ethical and legal limitations to using human embryos for research purposes, so scientists use alternative models including stem cell-based and animal models. In a new study published in Nature Cell Biology, Sophie Petropoulos, a researcher ...

The rise of "gut feelings" in US political rhetoric

2025-04-10
Discussion of "alternative facts" has gained sad notoriety in US politics. Yet the question has been around much longer: How do people conduct political debates – is the focus more on facts or personal opinions? A team of international researchers led by the Cluster of Excellence "The Politics of Inequality" looked into the matter. The researchers examined political rhetoric in eight million speeches by members of the US Congress between 1879 and 2022 to see if the focus of their language was more on data and facts or personal convictions and subjective interpretations. The team noticed a significant decline in the use of evidence-based political ...

How mothers adapt to the metabolic demands of nursing

2025-04-10
Nursing poses major metabolic demands on mothers, to which they respond by eating more and saving energy to sustain milk production. There are significant hormonal changes during lactation, but how they lead to metabolic adaptations in nursing mothers remained unclear. In this study, which appeared in Nature Metabolism, leading researchers at Baylor College of Medicine and Pennington Biomedical Research Center uncovered a mechanism that connects prolactin, estrogen, the brain and metabolic adaptations during lactation. “We worked with animal models to investigate ...

Caspian Sea decline threatens endangered seals, coastal communities and industry

Caspian Sea decline threatens endangered seals, coastal communities and industry
2025-04-10
UNDER EMBARGO UNTIL THURSDAY 10 APRIL, 10AM LONDON TIME, 5AM EASTERN TIME. Urgent action is needed to protect endangered species, human health and industry from the impacts of the Caspian Sea shrinking, research led by the University of Leeds has found. Water levels in the Caspian Sea – the world’s largest landlocked water body – are getting lower, as hotter temperatures cause more water to evaporate than is flowing in. Even if global warming is limited to below 2°C, ...

Landmark study identifies new genetic cause of neurodevelopmental disorders, bringing long-awaited answers to families

Landmark study identifies new genetic cause of neurodevelopmental disorders, bringing long-awaited answers to families
2025-04-10
New York, NY [April 10, 2025]—A seminal study from researchers at the Icahn School of Medicine at Mount Sinai and their collaborators in the United Kingdom, Belgium, Spain, the Netherlands, and Iceland has uncovered a new genetic cause of neurodevelopmental disorders (NDDs). The discovery offers both closure and hope to potentially thousands of families worldwide who have long been searching for answers. The study, published in the April 10 online issue of Nature Genetics [DOI: 10.1038/s41588-025-02159-5], reveals that mutations in a small, previously overlooked non-coding gene called RNU2-2 are responsible for relatively common NDD. Non-coding genes ...

Scientists create “metal detector” to hunt down tumors

2025-04-10
Researchers have created a “metal detector” algorithm called PRRDetect to hunt down vulnerable tumours, in a development that could one day revolutionise the treatment of cancer. In a paper published today (Thursday 10th April) in Nature Genetics, scientists funded by Cancer Research UK and the National Institute for Health and Care Research (NIHR) analysed the full DNA sequence of 4,775 tumours from seven types of cancer. Based at the University of Cambridge and NIHR Cambridge Biomedical Research Centre, they used that data from Genomics England’s 100,000 Genomes ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Poo-romising frontier in fecal microbiota transplantation